Multiple myeloma is an incurable hematologic malignancy, its early diagnosis is important. However, the biomarker for early diagnosis is limited...

Multiple myeloma (MM), a bone marrow-resident hematological malignancy of plasma cells, has remained largely incurable despite the recent advancement...

Early intervention in smoldering multiple myeloma (SMM) requires optimal risk stratification to avoid under- and overtreatment

The persistence or recurrence of symptoms in patients with coeliac disease (CD), despite a gluten-free diet (GFD), must prompt further work-up for...

The FNA cytological and morphological analysis of the reactive lymph node background revealed diffusely distributed non- homogeneous mixed lymphocytes...

We tested the utility of germinal center markers human germinal center-associated lymphoma (HGAL) and LIM- domain only 2 (LMO2) in detecting a TFH...

Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive lymphoid malignancy associated with a poor clinical prognosis. The AITL tumor...

In our study, time to initiation of systemic therapy was an independent prognostic factor in MM

Up to 30 000 cells were acquired and IGH chromosomal abnormalities were detected in 5 of the 10 marrow samples. FISH signal patterns seen included...

This study aimed to develop reliable nomogram-based predictive models that could guide prognostic stratification and individualized treatments in...

Multiple myeloma (MM) is characterized by copy number abnormalities (CNAs), some of which influence patient outcomes and are sometimes observed only...

The patients were divided into two groups according to the optimal value of the HALP score (low-score group: HALP ≤28.8 [n: 134] and high-score group...